<SEC-DOCUMENT>0001104659-21-088375-index.html : 20210701
<SEC-HEADER>0001104659-21-088375.hdr.sgml : 20210701
<ACCEPTANCE-DATETIME>20210701182943
ACCESSION NUMBER:		0001104659-21-088375
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20210402
FILED AS OF DATE:		20210701
DATE AS OF CHANGE:		20210701

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Eldridge George A
		CENTRAL INDEX KEY:			0001413006

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40544
		FILM NUMBER:		211067391

	MAIL ADDRESS:	
		STREET 1:		C/O TARGANTA THERAPEUTICS CORPORATION
		STREET 2:		222 THIRD STREET SUITE 2300
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aerovate Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001798749
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				831377888
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		200 BERKELEY STREET
		STREET 2:		FLOOR 18
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		617-443-2400

	MAIL ADDRESS:	
		STREET 1:		200 BERKELEY STREET
		STREET 2:		FLOOR 18
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>tm2121189-2_4seq1.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: tm2121189-2_4seq1.html

Document 1 - RAW XML: tm2121189-2_4seq1.xml

</DOCUMENT>
</SEC-DOCUMENT>